So, shout outs (some long overdue) to the people who have linked:
- Kevin, MD (On flaws in the Avandia meta-analysis and potential regulatory fallout)
- Peter Rost (On the statistical reporting system and how it could impact Novartis)
- Kitchen Table Math (A general link to the site)
- Captador (DCA)
- Highlight Health (DCA)